| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $67.48M | $53.88M | $0.00 | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $371.11M | $247.08M | $165.80M | $139.87M | $131.26M |
| R&D | $251.07M | $169.97M | $115.23M | $92.81M | $84.72M |
| SG&A | $119.98M | $77.11M | $50.57M | $47.05M | $46.54M |
| Operating Income | -$303.63M | -$193.19M | -$165.80M | -$139.87M | – |
| Interest Expense | – | – | $1.55M | $229.00K | $414.00K |
| Tax Expense | $297.00K | $2.02M | $0.00 | $0.00 | $0.00 |
| Net Income | -$278.67M | -$173.98M | -$152.63M | -$135.84M | -$130.47M |
| EPS (basic) | -3.1800 | -2.0200 | -2.0800 | -2.0300 | -1.9700 |
| EPS (diluted) | -3.1800 | -2.0200 | -2.0800 | -2.0300 | -1.9700 |
| Shares (diluted) | $87.68M | $86.16M | $73.23M | $66.99M | $66.35M |